Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 18 years of age at the time of joining the trial.
- People with a clinical diagnosis of moderate-to-severe chronic atopic dermatitis (also known as atopic eczema), where the treating doctor considers the treatment abrocitinib appropriate under its approved use.
- People who have been informed about the study procedures and have signed a consent form.
Who may not be able to join:
- People for whom the medication abrocitinib is medically unsuitable or contraindicated.
- People who are unable to follow the study procedures or answer the required study questions due to language, psychological, social, or geographic reasons, as judged by the investigator.
- People who are not registered with the French social security system.
- People who are in custody, under legal guardianship, or otherwise unable to give their own consent.
- People who are already taking part in another clinical trial testing a medicinal treatment (participation in registries or observatories is allowed).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Pfizer CT.gov Call Center, Pfizer
Phone: 1-800-718-1021
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients with an Investigator's Global Assessment (IGA) score of clear (0) or almost clear (1) (on a 5- point scale) and a reduction from baseline of ≥2 points
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.